tiprankstipranks
Verrica Pharmaceuticals (VRCA)
:VRCA
US Market

Verrica Pharmaceuticals (VRCA) Income Statement

Compare
441 Followers

Verrica Pharmaceuticals Income Statement

Last quarter (Q4 2024), Verrica Pharmaceuticals's total revenue was $344.00K, a decrease of -82.70% from the same quarter last year. In Q4, Verrica Pharmaceuticals's net income was $-16.20M. See Verrica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.57M$ 5.12M$ 9.03M$ 12.00M$ 0.00
Gross Profit
$ 5.71M$ 4.38M$ 8.31M$ 11.53M$ -229.00K
Operating Expenses
$ 71.63M$ 70.14M$ 29.60M$ 42.91M$ 40.18M
Depreciation and Amortization
$ 1.27M$ 836.00K$ 718.00K$ 472.00K$ 229.00K
EBITDA
$ -65.90M$ -62.20M$ -21.60M$ -30.31M$ -39.43M
Operating Income
$ -65.92M$ -65.76M$ -21.30M$ -30.91M$ -40.18M
Other Income/Expenses
$ -10.66M$ -1.24M$ -3.19M$ -4.17M$ -2.51M
Pretax Income
$ -76.58M$ -67.00M$ -24.49M$ -35.08M$ -42.69M
Net Income
$ -76.58M$ -67.00M$ -27.68M$ -38.90M$ -45.50M
Per Share Metrics
Basic EPS
$ -1.48$ -1.48$ -0.81$ -1.44$ -1.82
Diluted EPS
$ -1.48$ -1.48$ -0.81$ -1.44$ -1.82
Weighted Average Shares Outstanding
51.81M 45.34M 34.16M 27.04M 25.00M
Weighted Average Shares Outstanding (Diluted)
51.81M 45.34M 34.16M 27.04M 25.00M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis